Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1

M Leontien van der Bent, Melvin M Evers, Astrid Vallès uniQure biopharma B.V., Department of Research and Development, Amsterdam, the NetherlandsCorrespondence: Astrid Vallès, uniQure biopharma B.V, Postbus 22506, Amsterdam, 1100 DA, the Netherlands, Tel +31 20 240 6000, Email a.vallessanchez@uniqur...

Descripción completa

Detalles Bibliográficos

Autores principales:	van der Bent ML, Evers MM, Vallès A
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Dove Medical Press 2022-09-01
Colección:	Biologics: Targets & Therapy
Materias:	huntingtin n-terminal fragments proteolysis aberrant splicing exon1 fragment huntington’s disease therapeutics
Acceso en línea:	https://www.dovepress.com/emerging-therapies-for-huntingtons-disease--focus-on-n-terminal-huntin-peer-reviewed-fulltext-article-BTT
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!